A new era of cardiometabolic care: advancing holistic treatment ambitions with amylin

Chairs: Alice Cheng (CAN), Arya Sharma (DEU)

12:15 – 12:17Welcome and introduction

Alice Cheng (CAN)

Arya Sharma (DEU)

12:17 – 12:21Setting the scene: cardiometabolic management in people with obesity and T2DAlice Cheng (CAN)
12:21 – 12:25A match made in heaven: how can amylin complement incretin?Arya Sharma (DEU)
12:25 – 12:37Unleashing the power of two: amylin and incretins in clinical trials

Alice Cheng (CAN)

Arya Sharma (DEU)

12:37 – 12:43Q&A

Alice Cheng (CAN)

Arya Sharma (DEU)

12:43 – 12:45Summary and close

Alice Cheng (CAN)

Arya Sharma (DEU)

Novo Nordisk logo